Capsules

The exclusivity period and subsequent loss of exclusivity (LOE) are critical points in the lifecycle of any drug, particularly for...

New formulation strategies are beginning to yield clinically and commercially viable oral biological therapies, according to a Lonza whitepaper published...

Abstract As a major public health issue, chronic obstructive pulmonary disease (COPD) causes approximately 2.7 million deaths worldwide each year...

Enteric capsules are widely used to protect acid‑sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting...

Abstract Capsule aperture geometry is a tunable design parameter that can markedly influence powder emission and aerosol dispersion in capsule-based...

FROM CHALLENGE TO TRIUMPH Probiotics are highly sensitive to mechanical stress and moisture, making them difficult to formulate into direct...

Abstract The dynamic and transitory nature of the distal small intestine makes targeted drug delivery to this region particularly challenging....

Abstract Background/Objectives: Cholera remains an important global health problem. Inactivated oral cholera vaccines (OCVs) are essential in the WHO/GTFCC (World...

Abstract Passive antibiotic release from implanted depot systems often leads to sub-therapeutic dosing, which in some cases may increase the...

Capsugel®/ Lonza published a new podcast episode: For years, oral delivery of biologics has been viewed as impractical. But what...